Interesting Engineering on MSN9mon
Researchers find ‘molecular glue’ that makes memories last a lifetimeThe study focuses on the discovery of the role of a molecule called KIBRA ... The study says that KIBRA acts as a glue to ...
To achieve that kind of control, Choudhary and his colleagues added a special response element to the Cas9 enzyme and introduced a drug called pomalidomide, which acts as a molecular glue to bring ...
Monte Rosa Therapeutics’ plan to develop a molecular glue degrader in a wide range of cancers has come unstuck. Biomarker-positive patients were rarer than expected in some tumor types ...
the latest techniques for molecular glue drug discovery, and their application in the treatment of diseases. This ACS Webinar is moderated by Angela Zhou, Information Scientist at CAS and is ...
In March 2025, Magnet Biomedicine formed a partnership and licensing agreement with Eli Lilly to identify, develop, and market oncology-focused molecular glue therapeutics. In January 2025 ...
Takeda Pharmaceuticals & Degron Therapeutics (May 2024) – Developing novel molecular glue degraders for oncology, neuroscience, and inflammatory diseases. NEOsphere Biotechnologies & Kymera ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback